MIRA INFORM REPORT

 

 

Report Date :

10.11.2014

 

IDENTIFICATION DETAILS

 

Name :

BHARAT BIOTECH INTERNATIONAL LIMITED

 

 

Registered Office :

Genome Valley, Turkapally, Shamirpet Mandal, Hyderabad, Telangana

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

15.02.1996

 

 

Com. Reg. No.:

36-023232

 

 

Capital Investment / Paid-up Capital :

Rs.150.746 Million

 

 

CIN No.:

[Company Identification No.]

U24230TG1996PLC023232

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDB00771B

 

 

PAN No.:

[Permanent Account No.]

AABCB3822B

 

 

Legal Form :

A Closely held public limited liability company.

 

 

Line of Business :

Manufacturer of Vaccines

 

 

No. of Employees :

Information declined by the management.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (54)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 5900000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a well-established company having fine track record.

 

The rating reflects company’s healthy financial risk profile marked by comfortable capital structure and favorable operating margins of the company.

 

Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications : Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

                                                                                                     

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

CC = A-

Rating Explanation

Adequate degree of safety and low credit risk

Date

November, 2013

 

Rating Agency Name

ICRA

Rating

LC = A1

Rating Explanation

Very strong degree of safety and lowest credit risk

Date

November, 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED BY

 

Name :

Ms. Kameshwari

Designation :

Marketing Department

Contact No.:

91-40-23480567

Date :

03.11.2014

 

 

LOCATIONS

 

Registered Office :

Genome Valley, Turkapally, Shamirpet Mandal, Hyderabad, Telangana, India

Tel. No.:

091-40-23480567

Fax No.:

091-994-8080567

E-Mail :

careers@bharatbiotech.com

info@bharatbiotech.com

srinivas@bharatbiotech.com

subhash2393@bharatbiotech.com

Website :

http://www.bharatbiotech.com

Area :

20 acres

Location :

Owned

 

 

DIRECTORS

 

Name :

Dr. Krishna Murthy Ella

Designation :

Chairman cum Managing Director

Address :

1292A, Road No. 65, Jubilee Hills, Hyderabad - 500033

Date of Birth/Age :

10.07.1955

Date of Appointment :

01.11.1996

DIN No.:

00072071

Other Directorship :

S.

No.

CIN/LLPIN

Name of the Company/ LLP

 

 

 

 

 

                             

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230TG1996PLC023232

BHARAT BIOTECH INTERNATIONAL LIMITED

Managing director

25/09/2012

01/11/1996

-

Active

NO

2

U01122KA1997PTC021815

CENTURY BIOLOGICALS PRIVATE LIMITED

Director

14/02/1997

14/02/1997

-

Active

NO

3

U85110AP2002NPL039925

ELLA FOUNDATION

Director

15/11/2002

15/11/2002

-

Active

NO

4

U51219KA2005PLC035446

INNOVA AGRI BIO PARK LIMITED

Director

19/01/2005

19/01/2005

-

Active

NO

5

U24235KA2005PTC035491

BIOVET PRIVATE LIMITED

Director

27/01/2005

27/01/2005

01/12/2012

Active

NO

6

U51909MH2004PTC150142

MINDTREE TRADING COMPANY PRIVATE LIMITED

Director

21/09/2005

21/09/2005

01/12/2012

Active

NO

7

U73100TG2008PTC062147

CONRESS LABS (INDIA) PRIVATE LIMITED

Director

11/12/2008

11/12/2008

-

Active

NO

8

U24239TG2005PTC048111

RCC LABORATORIES INDIA PRIVATE LIMITED

Director

21/06/2010

12/01/2009

10/11/2011

Active

NO

9

L24110TG1991PLC012471

GRANULES INDIA LIMITED

Director

28/08/2014

04/06/2009

-

Active

NO

10

U45202OR2009PTC010902

ODISHA BIOTECH PARK PRIVATE LIMITED

Director

23/06/2009

23/06/2009

28/05/2013

Active

NO

 

 

Name :

Mrs. Suchitra Ella

Designation :

Joint Managing Director

Address :

1292A, Road No. 65, Jubilee Hills, Hyderabad – 500033, India

Date of Birth/Age :

15.07.1963

Date of Appointment :

25.10.1996

DIN No.:

 

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230TG1996PLC023232

BHARAT BIOTECH INTERNATIONAL LIMITED

Managing director

25/09/2012

25/10/1996

-

Active

NO

2

U01122KA1997PTC021815

CENTURY BIOLOGICALS PRIVATE LIMITED

Director

14/02/1997

14/02/1997

-

Active

NO

3

U85110AP2002NPL039925

ELLA FOUNDATION

Director

15/11/2002

15/11/2002

-

Active

NO

4

U73100KA2003PTC032309

CLINTRAC INTERNATIONAL PRIVATE LIMITED

Director

25/07/2003

25/07/2003

-

Active

NO

5

U51219KA2005PLC035446

INNOVA AGRI BIO PARK LIMITED

Director

19/01/2005

19/01/2005

-

Active

NO

6

U73100KA2008PTC046540

CLINSOFT RESEARCH AND IMAGING PRIVATE LIMITED

Director

23/05/2008

23/05/2008

-

Strike off

NO

7

U73100TG2008PTC062147

CONRESS LABS (INDIA) PRIVATE LIMITED

Director

11/12/2008

11/12/2008

-

Active

NO

8

U24239TG2005PTC048111

RCC LABORATORIES INDIA PRIVATE LIMITED

Director

21/06/2010

12/01/2009

06/09/2011

Active

NO

9

U85100TG2012NPL080040

HYDERABAD BICYCLING CLUB

Director

23/09/2013

02/06/2012

-

Active

NO

 

 

Name :

Dr. P.R. Rajagopalan

Designation :

Director

Address :

25 Charing Road, Charleston, SC, 294073402, United States of America

Date of Birth/Age :

12.10.1940

Date of Appointment :

30.09.1998

DIN No.:

03272757

 

 

Name :

Mr. Subrahmanya Bharathi Krishnan

Designation :

Director

Address :

Flot No. JGI, Navartna, 286 Anna Street, Omr Kottivakkam, Chennai – 600041, Tamil Nadu

Date of Birth/Age :

10.12.1940

Date of Appointment :

29.09.2004

DIN No.:

00017343

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U65993DL1988PLC030284

IFCI VENTURE CAPITAL FUNDS LIMITED

Director

16/10/1998

16/10/1998

02/07/2007

Active

NO

2

U24230TG1996PLC023232

BHARAT BIOTECH INTERNATIONAL LIMITED

Director

29/09/2014

29/09/2004

-

Active

NO

3

U85110TN1998PTC093106

RAVINDRANATH GE MEDICAL ASSOCIATES PRIVATE LIMITED

Director

27/09/2006

30/12/2005

-

Active

NO

4

U74900AP2008PTC060473

UNIVERSITY OF HYDERABAD KNOWLEDGE AND INNOVATION PARK PRIVATE LIMITED

Director

18/08/2008

18/08/2008

-

Active

YES

 

 

Name :

Dr. Krishna Mohan Vadrevu

Designation :

Whole-time Director

Address :

304 A Block, Gayatri Grandeur, Plot 18/19 Vikrampuri, Secunderabad – 500099, Andhra Pradesh, India

Date of Birth/Age :

17.02.1951

Date of Appointment :

28.12.2011

DIN No.:

05222871

 

 

KEY EXECUTIVES

 

Name :

Mr. Subhash Kishan Kandrapu

Designation :

Company Secretary

Address :

Flat No. 203, 2nd Floor, Nara Paradise, Dinakar Nagar, Neredmet, Hyderabad – 500056, India

Date of Birth/Age :

10.02.1985

Date of Appointment :

27.05.2013

PAN No. :

APRPK8726K

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2013

 

Names of  Equity Shareholders (Physical Holding)

No. of Shares

Suchitra Ella

716200

V. Sunder

100

T. Srinivas

100

Mahalakshmi

100

T. Janaki

100

Swarnalath Inderjith

52575

S. Balasunder

405092

Muralidhar Reddy

54075

Dhavalur Inderjith

54014

P.R. Rajagopalan

354539

Bio-tech Consortia Inc. – Bahamas

3312547

Venkat Ganupuru

89700

N.P. Nageswara Rao

3500

Nageswari

3500

Bhamini

3500

B R Jayalakshmi

3500

G. Amrutha

2330

D K Manjula

3500

Ramanjaneya

3500

International Finance Corporation – USA

500

Kalavathi

36000

Richard P Novick

4500

N. Sarojini Devi

90000

Total

5193472

 

 

Names of Equity Shareholders (Demat Holding)

No. of Shares

Krishna M Ella

4399782

Mindtree Trading Company Private Limited – India

907778

IL and FS Trust Company Limited

870000

Sudhasarda Vadlamudi

175000

R. Balakrishnan Raji

13448

India Advantage Fund – I (IDBI Trusteeship Services Limited)

500

Total

6366508

 

 

Names of Preference Shareholders (Physical Holding)

No. of Shares

India Advantage Fund – I (IDBI Trusteeship Services Limited)

1562004

International Finance Corporation

1757317

Krishna M Ella

195313

Total

3514634

 

As on 30.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

37.75

Bodies corporate

15.38

Directors or relatives of Directors

44.26

Other top fifty shareholders

2.60

Venture Capital

0.01

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Vaccines

 

 

Products :

Item Code No. (ITC Code)

Product Description

30068000

Pharmaceuticals

 

GENERAL INFORMATION

 

No. of Employees :

Information declined by the management.

 

 

Bankers :

  • HDFC Bank Limited, Emerging Corporate Group, 1- 10 - 60/3, 4th Floor,  Suryodaya, Begumpet, Hyderabad, Telangana – 500016 , INDIA
  • Citibank N.A, 1st Floor, Queens Plaza, Sardar Patel Road, Hyder 
    abad, Andhra Pradesh – 500003, INDIA
  • EXPORT-IMPORT BANK OF INDIA, Floor 21, Center One Building, World Trade Centre, Cuffee Parade, Mumbai, Maharashtra - 400005, INDIA
  • State Bank of India, Overseas Branch 2nd &3rd Floor, Rajala Centre Plot No. 241/A,Jubilee Hills, Hyderabad, Telangana – 500033, INDIA

 

 

Facilities :

SECURED LOANS

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Term loan from others

3.959

4.200

Rupee term loan from banks

236.644

422.158

SHORT TERM BORROWINGS

 

 

Secured Borrowings

712.167

654.010

Total

952.770

1080.368

 

 

 

Banking Relations :

---

 

 

Auditors :

 

Name :

B S R R and Company

Chartered Accountants

Address :

Reliance Humsafar IV Floor, Road No 11 Banjara Hills, Hyderabad- 500034, Andhra Pradesh, India 

PAN No.:

AAKFB1884H

 

 

Subsidiaries :

  • Ella Foundation

U85110AP2002NPL039925

  • Century Biologicals  Private Limited

U01122KA1997PTC021815

 

 

CAPITAL STRUCTURE

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

12000000

Equity Shares

Rs.10/-each

Rs.120.000 Million

 

 

 

 

4000000

Preference Shares

Rs.10/-each

Rs.40.000 Million

 

 

 

 

 

Total

 

Rs.160.000 Million

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

11559980

Equity Shares

Rs.10/-each

Rs.115.599 Million

 

 

 

 

3514634

Preference Shares

Rs.10/-each

Rs.35.146 Million

 

 

 

 

 

Total

 

Rs.150.745 Million

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

150.746

150.746

150.746

(b) Reserves & Surplus

1922.365

1730.513

1450.757

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

2073.111

1881.259

1601.503

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

440.323

641.778

682.041

(b) Deferred tax liabilities (Net)

143.466

137.806

112.418

(c) Other long term liabilities

20.820

17.738

14.802

(d) long-term provisions

2.241

5.978

5.496

Total Non-current Liabilities (3)

606.850

803.300

814.757

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

712.167

654.010

270.259

(b) Trade payables

92.303

728.725

890.750

(c) Other current liabilities

413.362

391.880

223.768

(d) Short-term provisions

3.616

41.041

6.895

Total Current Liabilities (4)

1221.448

1815.656

1391.672

 

 

 

 

TOTAL

3901.409

4500.215

3807.932

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1351.226

1382.612

748.315

(ii) Intangible Assets

26.807

71.835

115.518

(iii) Capital work-in-progress

148.984

52.196

518.227

(iv) Intangible assets under development

460.515

404.317

313.165

(b) Non-current Investments

0.473

0.473

0.473

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

164.934

98.225

92.303

(e) Other Non-current assets

7.753

2.553

2.553

Total Non-Current Assets

2160.692

2012.211

1790.554

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

80.000

0.000

0.000

(b) Inventories

1330.966

1409.113

952.883

(c) Trade receivables

138.802

639.081

482.254

(d) Cash and cash equivalents

141.885

388.329

440.425

(e) Short-term loans and advances

45.914

48.322

140.020

(f) Other current assets

3.150

3.159

1.796

Total Current Assets

1740.717

2488.004

2017.378

 

 

 

 

TOTAL

3901.409

4500.215

3807.932

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

Income

2962.069

2778.003

2249.834

 

Other Income

29.188

25.481

28.755

 

TOTAL (A)

2991.257

2803.484

2278.589

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1326.226

1838.866

1121.293

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

281.808

(371.620)

53.456

 

Employees benefits expense

168.077

150.807

105.394

 

Other expenses

560.558

595.187

445.232

 

TOTAL (B)

2336.669

2213.240

1725.375

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (C)

654.588

590.244

553.214

 

 

 

 

 

Less

FINANCIAL EXPENSES (D)

126.500

88.361

40.175

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)

528.088

501.883

513.039

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION (F)

252.978

158.761

147.285

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)   (G)

275.110

343.122

365.754

 

 

 

 

 

Less

TAX (I)

82.850

62.958

120.197

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-I)   (J)

192.260

280.164

245.557

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

 

 

 

 

Freight

 

 

 

 

Insurance

 

 

 

 

TOTAL EARNINGS

170.879

292.821

0.000

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

16.63

24.24

21.24

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

 

31.03.2012

 

31.03.2011

 

 

 

 

 

 

Net Profit Margin

PAT / Sales

(%)

6.43

 

9.99

 

10.78

 

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

22.09

21.24

24.58

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

8.36

 

8.49

 

12.29

 

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.13

 

0.18

 

0.23

 

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.56

 

0.69

 

0.59

 

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.43

 

1.37

 

1.45

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

150.746

150.746

150.746

Reserves & Surplus

1450.757

1730.513

1922.365

Net worth

1601.503

1881.259

2073.111

 

 

 

 

long-term borrowings

682.041

641.778

440.323

Short term borrowings

270.259

654.010

712.167

Total borrowings

952.300

1295.788

1152.490

Debt/Equity ratio

0.595

0.689

0.556

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2249.834

2778.003

2962.069

 

 

23.476

6.626

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

2249.834

2778.003

2962.069

Profit

245.557

280.164

192.260

 

10.91%

10.09%

6.49%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10515093

23/07/2014

250,000,000.00

HDFC BANK LIMITED

Emerging Corporate Group, 1- 10 - 60/3, 4th floor, Suryodaya, Begumpet, Hyderabad, Telangana - 500016, INDIA

C16520488

2

10416183

28/03/2013

250,000,000.00

Citibank N.A

1st Floor, Queens Plaza, Sardar Patel Road, Hyderabad, Andhra Pradesh -500003, INDIA

B71924831

3

10231369

16/06/2011 *

500,000,000.00

EXPORT-IMPORT BANK OF INDIA

Floor 21, Center One Building, World Trade Centre, Cuffee Parade, Mumbai, Maharashtra - 400005, INDIA

B17360785

4

10198537

26/12/2009

39,339,000.00

DEPARTMENT OF BIOTECHNOLOGY GOVERNMENT OF INDIA

BLOCK 2, CGO COMPLEX, LODHI ROAD, NEW DELHI, Delhi - 110003,

INDIA

A77778579

5

10058499

15/06/2007

109,000,000.00

TECHNOLOGY DEVELOPMENT BOARD

WING A ( GROUND FLOOR), VISHWAKARMA BHAVAN, SHAHE 
ED JEET SINGH MARG, NEW DELHI, Delhi - 110067, INDIA

A18259887

6

90124049

19/06/2014 *

2,110,000,000.00

State Bank of India

Overseas Branch 2nd &3rd Floor, Rajala Centre Plot No. 241/A,Jubilee Hills, Hyderabad, Telangana - 
500033, INDIA

C08824344

7

90121193

07/04/1998

5,000,000.00

CENTRE FOR TACHNOLOGY DEVELOPMENT

CSIC COMPLEX 2SC CANOYS, POST BOX NO 1209, BANGLORE, Karnataka, INDIA

-

 

 

LITIGATION DETAILS :

CASE DETAILS

CMA 311/2010                                                   CMASR 6055 / 2009                                   CASE IS : PENDING         

Petitioner: INDIAN IMMUNOLOGICALS LTD.,       VS       Respondent: BHARAT BIOTECH INTERNATIONAL                       

                                                              LTD.,             

 

Petn. Adv : RAMESH BABU VISHWANATH AND              Resp.ADV.: SRINIVAS DAMMALAPATI    

NASARAIAH GOLLA                                     

 

 SUBJECT : ORDER 43                                                                                                 District: HYDERABAD

FILING DATE :20.02.2009                                                       POSTING STAGE : INTERLOCUTORY

 

Status: NOTICES                                                                     LISTING DATE : 13.04.2010

                                                                                                                    

REG. DATE : 17.04.2010

                                                                                            

Last Coram:

HON'BLE SHRI JUSTICE K.C.BHANU

 

 

UNSECURED LOANS

 

PARTICULAR

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Term loan

132.790

148.715

Deferred payment liabilities

66.930

66.704

Total

199.720

215.419

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.41

UK Pound

1

Rs.98.06

Euro

1

Rs.76.66

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

PNM


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

---

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.